Condition
Organoids clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Organoids clinical trials that are recruiting, at sites in 4 countries (most in Italy (2), China (2), Switzerland (1)). By phase: Phase 2 (1). The most active sponsors are Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2), Second Affiliated Hospital, Zhejiang University, School of Medicine (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Organoids clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Using organoid models to study liver cancer | — | Roma | Recruiting | Apr 16, 2025 |
| Using precision medicine to choose chemotherapy for metastatic colorectal cancer | Phase 2 | Trondheim | Recruiting | Apr 2, 2025 |
| Evaluating drug sensitivity in organoids from breast cancer patients with fluid buildup | — | Hangzhou, Zhejiang and 2 other locations | Recruiting | Oct 26, 2024 |
| Characterizing breast cancer subtypes using patient-derived organoids | — | Roma | Recruiting | Mar 18, 2024 |
| Using organoids to test chemotherapy sensitivity in breast cancer patients | — | Hangzhou, Zhejiang | Recruiting | Dec 4, 2023 |
| Study of human organoids to understand host-microbe interactions | — | Bern | Recruiting | Apr 12, 2022 |
All recruiting trials (6)
-
Using organoid models to study liver cancer
This study is trying to create mini-livers from patients' liver tissue to see how liver cancer behaves and how well different treatments work for people with the disease.
-
Using precision medicine to choose chemotherapy for metastatic colorectal cancer
This study is testing whether a new way to choose the best chemotherapy for people with metastatic colorectal cancer can help them live longer and feel better.
-
Evaluating drug sensitivity in organoids from breast cancer patients with fluid buildup
This study is testing how well standard chemotherapy drugs work on lab-grown samples from breast cancer patients with fluid buildup to help personalize their treatment.
-
Characterizing breast cancer subtypes using patient-derived organoids
This study is testing if lab-grown mini-tumors from breast cancer patients can help doctors figure out which chemotherapy works best for people with triple-negative breast cancer or those whose cancer has come back.
-
Using organoids to test chemotherapy sensitivity in breast cancer patients
This study is testing if lab-grown mini tumors from breast cancer patients can help predict how well they will respond to chemotherapy before treatment starts.
-
Study of human organoids to understand host-microbe interactions
This study is trying to see how the tiny organisms in our gut interact with our body by using samples from people getting endoscopies to grow mini versions of their intestines.
Related topics
Quick answers
How many Organoids clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Italy (2 trials), China (2 trials), Switzerland (1 trial), Norway (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.